Two-stage estimation to adjust for treatment switching in randomised trials: a simulation study investigating the use of inverse probability weighting instead of re-censoring

Overview of attention for article published in BMC Medical Research Methodology, March 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (70th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

policy: 1 policy source

twitter: 4 X users

Citations

dimensions_citation: 18 Dimensions

Readers on

mendeley: 30 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 2 policy documents that reference this research output.

Brentuximab vedotin in combination for untreated systemic anaplastic large cell lymphoma : Committee papers

Cited by National Institute for Health and Care Excellence on 02 Jul 2020

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Isatuximab with pomalidomide and dexamethasone for treating relapsed and refractory multiple myeloma : Appraisal consultation committee papers

Cited by National Institute for Health and Care Excellence on 28 May 2020

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.